David Setboun

Bio:

David Setbound is the CEO of PharmatrophiX. He brings 20+ years of experience building and scaling biotech and pharmaceutical organizations in neurology, rare disease, oncology, and aging science. Prior to joining PharmatrophiX, Setboun held senior roles at AstraZeneca, Eli Lilly, Biogen, and Alkeus Pharmaceuticals across both large-cap pharmaceutical and high-growth biotech organizations.

Dr. Setboun received his Pharmaceutical Doctorate (Pharm.D.) from University Paris XI and his MBA from H.E.C Paris. More recently, David graduated from Harvard Business School.